Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Bristol Myers Squibb Co (BMY)
since 2015 are shown in Table 1 and Table 2.
Table 1 shows the monthly insider trading data of Bristol Myers Squibb Co.
(See page 1 of this report.) Table 2 shows the detailed insider transactions.
This company's CIK number is 14272.
Total stock buying since 2015: $3,732,641.
Total stock sales since 2015: $206,100,092.
Total stock option exercises since 2015: $70,354,798.
Table 3. Detailed insider trading at Bristol Myers Squibb Co (BMY) , Part 2
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2020-12-31 | Ahmed Nadim (EVP and President, Hematology) | Option Ex | 14,946 | .00 | 0 |
| 2020-12-31 | Vessey Rupert (EVP, Research & Early Dev.) | Option Ex | 25,866 | .00 | 0 |
| 2020-12-31 | Elkins David V (EVP, Chief Financial Officer) | Option Ex | 20,624 | .00 | 0 |
| 2020-12-02 | Ahmed Nadim (EVP and President, Hematology) | Option Ex | 6,594 | .00 | 0 |
| 2020-12-02 | Vessey Rupert (EVP, Research & Early Dev.) | Option Ex | 8,792 | .00 | 0 |
| 2020-12-02 | Boerner Christopher S. (EVP, Chief Commercial Officer) | Option Ex | 2,637 | .00 | 0 |
| 2020-12-02 | Elkins David V (EVP, Chief Financial Officer) | Option Ex | 8,792 | .00 | 0 |
| 2020-12-01 | Eid Joseph (SVP,Head Glob. Medical Affairs) | Option Ex | 2,825 | .00 | 0 |
| 2020-11-25 | Von Autenried Paul (EVP, Chief Information Officer) | Sale | 3 | 63.50 | 190 |
| 2020-11-24 | Dubow Adam (SVP,ChiefCompliance&EthicsOff.) | Sale | 900 | 63.39 | 57,051 |
| 2020-11-24 | Von Autenried Paul (EVP, Chief Information Officer) | Sale | 20,000 | 62.75 | 1,255,000 |
| 2020-11-23 | Vessey Rupert (EVP, Research & Early Dev.) | Sale | 13,421 | 61.34 | 823,244 |
| 2020-11-19 | Vessey Rupert (EVP, Research & Early Dev.) | Sale | 57,591 | 61.28 | 3,529,176 |
| 2020-11-19 | Vessey Rupert (EVP, Research & Early Dev.) | Option Ex | 52,213 | 48.03 | 2,507,790 |
| 2020-10-30 | Ahmed Nadim (EVP and President, Hematology) | Option Ex | 4,650 | .00 | 0 |
| 2020-10-30 | Vessey Rupert (EVP, Research & Early Dev.) | Option Ex | 5,804 | .00 | 0 |
| 2020-09-01 | Santiago Karen Murphy (SVP & Controller) | Option Ex | 642 | .00 | 0 |
| 2020-08-31 | Caforio Giovanni (Chairman and CEO) | Sale | 39,840 | 62.70 | 2,497,968 |
| 2020-08-17 | Eid Joseph (SVP,Head Glob. Medical Affairs) | Sale | 5,327 | 64.00 | 340,928 |
| 2020-08-13 | Leung Sandra (EVP, General Counsel) | Sale | 141,420 | 63.24 | 8,943,400 |
| 2020-08-01 | Elkins David V (EVP, Chief Financial Officer) | Option Ex | 46,402 | .00 | 0 |
| 2020-07-01 | Hirawat Samit (EVP,Chief Med.Offr.,Drug Dev.) | Option Ex | 9,356 | .00 | 0 |
| 2020-07-01 | Santiago Karen Murphy (SVP & Controller) | Option Ex | 1,069 | .00 | 0 |
| 2020-06-15 | Paliwal Dinesh C | Buy | 9,174 | 54.50 | 499,983 |
| 2020-06-14 | Haller Julia A | Option Ex | 558 | .00 | 0 |
| 2020-06-14 | Bonney Michael W | Option Ex | 558 | .00 | 0 |
| 2020-06-13 | Haller Julia A | Option Ex | 903 | .00 | 0 |
| 2020-06-13 | Bonney Michael W | Option Ex | 903 | .00 | 0 |
| 2020-06-03 | Eid Joseph (SVP,Head Glob. Medical Affairs) | Option Ex | 2,154 | .00 | 0 |
| 2020-06-03 | Haller Julia A | Option Ex | 2,949 | .00 | 0 |
| 2020-06-03 | Bonney Michael W | Option Ex | 2,949 | .00 | 0 |
| 2020-05-22 | Dubow Adam (SVP,ChiefCompliance&EthicsOff.) | Sale | 3,200 | 61.01 | 195,232 |
| 2020-05-19 | Schmukler Louis S (EVP,Pres.,Glob.Prod. & Supply) | Sale | 25,000 | 62.68 | 1,567,000 |
| 2020-05-01 | Ahmed Nadim (EVP and President, Hematology) | Option Ex | 2,908 | .00 | 0 |
| 2020-05-01 | Vessey Rupert (EVP, Research & Early Dev.) | Option Ex | 10,707 | .00 | 0 |
| 2020-03-10 | Eid Joseph (SVP,Head Glob. Medical Affairs) | Option Ex | 1,571 | .00 | 0 |
| 2020-03-10 | Dubow Adam (SVP,ChiefCompliance&EthicsOff.) | Option Ex | 5,007 | .00 | 0 |
| 2020-03-10 | Santiago Karen Murphy (Controller) | Option Ex | 5,063 | .00 | 0 |
| 2020-03-10 | Powell Ann (EVP, Chief Human Resources) | Option Ex | 31,169 | .00 | 0 |
| 2020-03-10 | Elicker John E (EVP, Investor Relations) | Option Ex | 18,407 | .00 | 0 |
| 2020-03-10 | Boerner Christopher S. (EVP, Chief Commercial Officer) | Option Ex | 21,426 | .00 | 0 |
| 2020-03-10 | Caforio Giovanni (Chairman and CEO) | Option Ex | 211,796 | .00 | 0 |
| 2020-03-10 | Schmukler Louis S (EVP,Pres.,Glob.Prod. & Supply) | Option Ex | 30,519 | .00 | 0 |
| 2020-03-10 | Von Autenried Paul (EVP, Chief Information Officer) | Option Ex | 20,806 | .00 | 0 |
| 2020-03-10 | Bancroft Charles A (EVP, Head of Integration) | Option Ex | 71,868 | .00 | 0 |
| 2020-03-10 | Leung Sandra (EVP, General Counsel) | Option Ex | 51,598 | .00 | 0 |
| 2020-03-04 | Elicker John E (EVP, Investor Relations) | Sale | 15,805 | 61.01 | 964,263 |
| 2020-03-02 | Vessey Rupert (Pres., Research & Early Dev.) | Sale | 84,308 | 60.59 | 5,108,221 |
| 2020-03-02 | Vessey Rupert (Pres., Research & Early Dev.) | Option Ex | 93,468 | 48.03 | 4,489,268 |
| 2020-03-01 | Ahmed Nadim (President, Hematology) | Option Ex | 17,204 | .00 | 0 |
| 2020-03-01 | Vessey Rupert (Pres., Research & Early Dev.) | Option Ex | 23,349 | .00 | 0 |
| 2020-03-01 | Elkins David V (EVP, Chief Financial Officer) | Option Ex | 24,579 | .00 | 0 |
| 2020-02-04 | Ahmed Nadim (President, Hematology) | Option Ex | 2,076 | .00 | 0 |
| 2020-02-04 | Vessey Rupert (Pres., Research & Early Dev.) | Option Ex | 3,592 | .00 | 0 |
| 2019-12-31 | Vessey Rupert (Pres., Research & Early Dev.) | Option Ex | 16,060 | .00 | 0 |
| 2019-12-31 | Elkins David V (EVP, Chief Financial Officer) | Option Ex | 12,373 | .00 | 0 |
| 2019-12-05 | Dubow Adam (Chief Compliance & Ethics Officer) | Sale | 1,740 | 58.81 | 102,329 |
| 2019-12-04 | Bonney Michael W | Buy | 88 | 58.90 | 5,183 |
| 2019-12-01 | Eid Joseph (SVPHead Global Medical Affairs) | Option Ex | 2,825 | .00 | 0 |
| 2019-11-05 | Elicker John E (SVP, Public Affairs & IR) | Sale | 15,000 | 56.66 | 849,900 |
| 2019-11-05 | Schmukler Louis S (Pres., Global Mfg. & Supply) | Sale | 25,000 | 56.56 | 1,414,000 |
| 2019-10-02 | Biondi Paul (SVP, Head of Strategy & BD) | Option Ex | 592 | .00 | 0 |
| 2019-09-01 | Santiago Karen Murphy (Controller) | Option Ex | 641 | .00 | 0 |
| 2019-07-31 | Bertolini Robert J | Buy | 11,000 | 44.72 | 491,920 |
| 2019-05-16 | Santiago Karen Murphy (Controller) | Sale | 3,065 | 47.56 | 145,771 |
| 2019-05-16 | Samuels Theodore R. Ii | Buy | 5,000 | 47.29 | 236,439 |
| 2019-05-05 | Caforio Giovanni (Chairman and CEO) | Option Ex | 8,040 | .00 | 0 |
| 2019-04-03 | Lynch Thomas J. Jr. (EVP & Chief Scientific Officer) | Option Ex | 11,594 | .00 | 0 |
| 2019-03-10 | Biondi Paul (SVP, Head of Strategy & BD) | Option Ex | 8,619 | .00 | 0 |
| 2019-03-10 | Dubow Adam (Chief Compliance & Ethics Officer) | Option Ex | 3,735 | .00 | 0 |
| 2019-03-10 | Santiago Karen Murphy (Controller) | Option Ex | 3,825 | .00 | 0 |
| 2019-03-10 | Judge Ann Powell (SVP, Global Human Resources) | Option Ex | 25,577 | .00 | 0 |
| 2019-03-10 | Elicker John E (SVP, Public Affairs & IR) | Option Ex | 14,180 | .00 | 0 |
| 2019-03-10 | Boerner Christopher S. (EVP, Chief Commercial Officer) | Option Ex | 15,707 | .00 | 0 |
| 2019-03-10 | Caforio Giovanni (Chairman and CEO) | Option Ex | 173,419 | .00 | 0 |
| 2019-03-10 | Schmukler Louis S (Pres., Global Mfg. & Supply) | Option Ex | 26,568 | .00 | 0 |
| 2019-03-10 | Von Autenried Paul (SVP, Enterp. Services & CIO) | Option Ex | 19,925 | .00 | 0 |
| 2019-03-10 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 62,255 | .00 | 0 |
| 2019-03-10 | Lynch Thomas J. Jr. (EVP & Chief Scientific Officer) | Option Ex | 5,864 | .00 | 0 |
| 2019-03-10 | Leung Sandra (EVP, General Counsel) | Option Ex | 45,170 | .00 | 0 |
| 2019-02-28 | Leung Sandra (EVP, General Counsel) | Option Ex | 169,893 | 17.51 | 2,974,826 |
| 2019-02-02 | Boerner Christopher S. (EVP, Chief Commercial Officer) | Option Ex | 4,465 | .00 | 0 |
| 2018-12-02 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 6,401 | .00 | 0 |
| 2018-10-02 | Biondi Paul (SVP, Head of Strategy & BD) | Option Ex | 592 | .00 | 0 |
| 2018-09-03 | Dubow Adam (Chief Compliance & Ethics Officer) | Option Ex | 797 | .00 | 0 |
| 2018-09-01 | Santiago Karen Murphy (Controller) | Option Ex | 641 | .00 | 0 |
| 2018-08-01 | Gordon Murdo (EVP, Chief Commercial Officer) | Option Ex | 1,510 | .00 | 0 |
| 2018-07-01 | Biondi Paul (SVP, Head of Strategy & BD) | Option Ex | 1,461 | .00 | 0 |
| 2018-05-05 | Caforio Giovanni (Chairman and CEO) | Option Ex | 8,040 | .00 | 0 |
| 2018-04-30 | Paliwal Dinesh C | Buy | 4,770 | 52.40 | 249,948 |
| 2018-04-03 | Lynch Thomas J. Jr. (EVP & Chief Scientific Officer) | Option Ex | 12,367 | .00 | 0 |
| 2018-03-10 | Santiago Karen Murphy (Controller) | Option Ex | 4,407 | .00 | 0 |
| 2018-03-10 | Gordon Murdo (EVP, Chief Commercial Officer) | Option Ex | 39,235 | .00 | 0 |
| 2018-03-10 | Judge Ann Powell (SVP, Global Human Resources) | Option Ex | 36,044 | .00 | 0 |
| 2018-03-10 | Elicker John E (SVP, Public Affairs & IR) | Option Ex | 20,043 | .00 | 0 |
| 2018-03-10 | Caforio Giovanni (Chairman and CEO) | Option Ex | 219,211 | .00 | 0 |
| 2018-03-10 | Schmukler Louis S (Pres., Global Mfg. & Supply) | Option Ex | 34,681 | .00 | 0 |
| 2018-03-10 | Von Autenried Paul (SVP, Enterp. Services & CIO) | Option Ex | 31,275 | .00 | 0 |
| 2018-03-10 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 91,318 | .00 | 0 |
| 2018-03-10 | Leung Sandra (EVP, General Counsel) | Option Ex | 68,896 | .00 | 0 |
| 2018-02-23 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 37,460 | 22.14 | 829,364 |
| 2017-12-15 | Samuels Theodore R. Ii | Buy | 4,000 | 62.30 | 249,188 |
| 2017-12-12 | Lynch Thomas J. Jr. (EVP & Chief Scientific Officer) | Sale | 5,300 | 63.24 | 335,172 |
| 2017-12-04 | Leung Sandra (EVP, General Counsel) | Sale | 156,582 | 63.37 | 9,922,601 |
| 2017-12-04 | Leung Sandra (EVP, General Counsel) | Option Ex | 156,582 | 22.14 | 3,466,725 |
| 2017-12-02 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 6,401 | .00 | 0 |
| 2017-11-01 | Elicker John E (SVP, Public Affairs & IR) | Option Ex | 494 | .00 | 0 |
| 2017-09-06 | Caldarella Joseph C (SVP & Controller) | Sale | 9,340 | 60.00 | 560,400 |
| 2017-09-03 | Nielsen Anne (Chief Compliance & Ethics Officer) | Option Ex | 1,594 | .00 | 0 |
| 2017-08-02 | Samuels Theodore R. Ii | Buy | 6,000 | 55.94 | 335,622 |
| 2017-08-01 | Gordon Murdo (EVP, Chief Commercial Officer) | Option Ex | 1,510 | .00 | 0 |
| 2017-05-14 | Lynch Thomas J. Jr. (EVP & Chief Scientific Officer) | Option Ex | 14,550 | .00 | 0 |
| 2017-05-05 | Caforio Giovanni (Chairman and CEO) | Option Ex | 8,040 | .00 | 0 |
| 2017-04-07 | Andreotti Lamberto | Sale | 17,000 | 53.22 | 904,791 |
| 2017-04-06 | Andreotti Lamberto | Sale | 17,000 | 53.29 | 905,964 |
| 2017-04-01 | Judge Ann Powell (SVP, Global Human Resources) | Option Ex | 1,554 | .00 | 0 |
| 2017-03-28 | Andreotti Lamberto | Sale | 17,000 | 56.20 | 955,366 |
| 2017-03-27 | Andreotti Lamberto | Sale | 17,000 | 56.14 | 954,448 |
| 2017-03-17 | Schmukler Louis S (Pres., Global Mfg. & Supply) | Sale | 5,000 | 56.49 | 282,470 |
| 2017-03-15 | Caldarella Joseph C (SVP & Controller) | Sale | 8,096 | 57.28 | 463,779 |
| 2017-03-14 | Schmukler Louis S (Pres., Global Mfg. & Supply) | Sale | 15,000 | 56.75 | 851,220 |
| 2017-03-10 | Gordon Murdo (EVP, Chief Commercial Officer) | Option Ex | 25,592 | .00 | 0 |
| 2017-03-10 | Blin Emmanuel (SVP, Chief Strategy Officer) | Option Ex | 13,275 | .00 | 0 |
| 2017-03-10 | Nielsen Anne (Chief Compliance & Ethics Officer) | Option Ex | 13,696 | .00 | 0 |
| 2017-03-10 | Judge Ann Powell (SVP, Global Human Resources) | Option Ex | 31,513 | .00 | 0 |
| 2017-03-10 | Elicker John E (SVP, Public Affairs & IR) | Option Ex | 18,799 | .00 | 0 |
| 2017-03-10 | Caforio Giovanni (Chief Executive Officer) | Option Ex | 87,604 | .00 | 0 |
| 2017-03-10 | Schmukler Louis S (Pres., Global Mfg. & Supply) | Option Ex | 33,271 | .00 | 0 |
| 2017-03-10 | Von Autenried Paul (SVP, Enterp. Services & CIO) | Option Ex | 31,721 | .00 | 0 |
| 2017-03-10 | Cuss Francis M (EVP & CSO) | Option Ex | 66,726 | .00 | 0 |
| 2017-03-10 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 87,324 | .00 | 0 |
| 2017-03-10 | Caldarella Joseph C (SVP & Controller) | Option Ex | 15,484 | .00 | 0 |
| 2017-03-10 | Andreotti Lamberto | Option Ex | 102,174 | .00 | 0 |
| 2017-03-10 | Leung Sandra (EVP, General Counsel) | Option Ex | 65,424 | .00 | 0 |
| 2017-02-28 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 22,598 | 27.01 | 610,371 |
| 2017-02-27 | Samuels Theodore R. Ii | Buy | 12,000 | 56.77 | 681,240 |
| 2017-01-30 | Andreotti Lamberto | Option Ex | 100,000 | 27.01 | 2,701,000 |
| 2017-01-03 | Elicker John E (SVP, Public Affairs & IR) | Option Ex | 950 | .00 | 0 |
| 2016-12-02 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 19,209 | .00 | 0 |
| 2016-11-01 | Elicker John E (SVP, Public Affairs & IR) | Option Ex | 494 | .00 | 0 |
| 2016-11-01 | Bancroft Charles A (EVP & Chief Financial Officer) | Option Ex | 3,100 | .00 | 0 |
| 2016-11-01 | Andreotti Lamberto | Option Ex | 305,909 | 22.14 | 6,772,825 |
| 2016-10-11 | Andreotti Lamberto | Option Ex | 368,706 | 17.51 | 6,456,042 |
| 2016-09-08 | Andreotti Lamberto | Sale | 10,800 | 56.97 | 615,276 |
| 2016-09-07 | Andreotti Lamberto | Sale | 10,800 | 56.77 | 613,116 |
| 2016-09-03 | Nielsen Anne (Chief Compliance & Ethics Officer) | Option Ex | 1,596 | .00 | 0 |
| 2016-08-25 | Andreotti Lamberto | Sale | 11,600 | 58.92 | 683,472 |
| 2016-08-24 | Andreotti Lamberto | Sale | 11,600 | 59.26 | 687,358 |
| 2016-08-01 | Gordon Murdo (EVP, Chief Commercial Officer) | Option Ex | 1,511 | .00 | 0 |
| 2016-07-08 | Andreotti Lamberto | Sale | 11,600 | 75.05 | 870,522 |
Insider trading activities including stock purchases, stock sales, and option exercises
of BMY listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of Bristol Myers Squibb Co (symbol BMY,
CIK number 14272) see
the Securities and Exchange Commission (SEC) website.